Azacitidin Stada 100 mg, Pulver zur Herstellung einer Injektionssuspension

7680692380012 CH-69238 Pulver zur Herstellung einer Injektionssuspension
Azacitidin Stada 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Stada 100 mg, Pulver zur Herstellung einer Injektionssuspension
Azacitidin Stada 100 mg, Pulver zur Herstellung einer Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver zur Herstellung einer Injektionssuspension
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/01/2025
Summary of Product Characteristics
Français
14/01/2025
Summary of Product Characteristics
Italien
14/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 253.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69238
Drug name
Azacitidin Stada, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULIS
ATC Code
L01BC07
Authorization status
Z
Dispensing category
A
First authorization
18/09/2023
Authorization expiration date
17/09/2028
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
AZACITIDIN Stada subst sèche 100 mg flac
Description (DE)
AZACITIDIN Stada Trockensub 100 mg Durchstf
Market launch
18/09/2023
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75
View original

Other package sizes (1)

AZACITIDIN Stada subst sèche 150 mg flac
1 DUR
GTIN: 7680692380029
View